Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

ClinicalTrials.gov ID: NCT01005888

Public ClinicalTrials.gov record NCT01005888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

LEVP2005-1/Part B: A Double-blind, Placebo-Controlled, Clinical Study to Investigate the Efficacy and Safety of Purified C1 Esterase Inhibitor (Human) as Prophylactic Treatment to Prevent HAE Attacks

Study identification

NCT ID
NCT01005888
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
26 participants

Conditions and interventions

Interventions

  • C1 esterase inhibitor [human] (C1INH-nf) Biological
  • Placebo (saline) Drug

Biological · Drug

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 13, 2005
Primary completion
Aug 21, 2007
Completion
Aug 21, 2007
Last update posted
Jun 10, 2021

2005 – 2007

United States locations

U.S. sites
16
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
Allergy and Immunology Associates Scottsdale Arizona 85251
University of California, San Diego San Diego California 92093-0732
Allergy and Asthma Clinical Research, Inc Walnut Creek California 94598
Atlanta Allergy and Asthma Clinic Suwanee Georgia 30024
Hawaii Pacific Health Research Institute Honolulu Hawaii 96826
Welborn Clinic Allergy and Immunology Evansville Indiana 47713
Lake Charles Memorial Hospital Lake Charles Louisiana 70601
Institute for Asthma and Allergy Wheaton Maryland 20902
Libby Clinic Libby Montana 59923
Mount Sinai School of Medicine New York New York 10029
Nationwide Childrens Hospital Clinical Research Columbus Ohio 43205
Allergy Clinic of Tulsa Tulsa Oklahoma 74133
Allergy Asthma and Dermatology Research Center Lake Oswego Oregon 97035
AARA Research Center Dallas Texas 75231
Tyler County Hospital Woodville Texas 75979
St. Joseph's Hospital/Cornerstone Healthcare Parkersburg West Virginia 26101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01005888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01005888 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →